As of Mar 24
| +0.39 / +0.92%|
The 13 analysts offering 12-month price forecasts for Integra LifeSciences Holdings Corp have a median target of 48.00, with a high estimate of 55.00 and a low estimate of 42.00. The median estimate represents a +12.31% increase from the last price of 42.74.
The current consensus among 17 polled investment analysts is to Buy stock in Integra LifeSciences Holdings Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.